Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Ilson

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|October 8, 2013
Angiogenesis in gastric cancer: hitting the target?David H Ilson
Chinese Clinical Oncology|November 14, 2017
Adenocarcinoma of the esophagus: controversies and consensusDavid H Ilson
Current Opinion in Gastroenterology|September 5, 2020
Advances in the treatment of gastric cancerDavid H Ilson
Hematology/Oncology Clinics of North America|February 20, 2024
Malignancies of the Upper Gastrointestinal TractDavid H Ilson
Current Opinion in Gastroenterology|September 7, 2023
Advances in the treatment of gastric cancer: 2022-2023David H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Targeting the Vascular Endothelial Growth Factor Pathway in Gastric Cancer: A Hit or a Miss?David H Ilson
Chinese Clinical Oncology|February 4, 2020
Carcinomatosis in gastric cancer: the potential for cytoreductive surgery and intraperitoneal chemotherapyDavid H Ilson
The Lancet. Gastroenterology & Hepatology|January 26, 2019
Stage II gastric cancer: 1 year of S-1 remains standard of careDavid H Ilson
Current Treatment Options in Oncology|August 15, 2006
Cancer of the gastroesophageal junction: Current therapy optionsDavid H Ilson
Gastrointestinal Cancer Research : GCR|March 5, 2009
Esophageal cancer chemotherapy: recent advancesDavid H Ilson
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|October 8, 2013
Angiogenesis in gastric cancer: hitting the target?David H Ilson
Chinese Clinical Oncology|November 14, 2017
Adenocarcinoma of the esophagus: controversies and consensusDavid H Ilson
Current Opinion in Gastroenterology|September 5, 2020
Advances in the treatment of gastric cancerDavid H Ilson
Hematology/Oncology Clinics of North America|February 20, 2024
Malignancies of the Upper Gastrointestinal TractDavid H Ilson
Current Opinion in Gastroenterology|September 7, 2023
Advances in the treatment of gastric cancer: 2022-2023David H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Targeting the Vascular Endothelial Growth Factor Pathway in Gastric Cancer: A Hit or a Miss?David H Ilson
Chinese Clinical Oncology|February 4, 2020
Carcinomatosis in gastric cancer: the potential for cytoreductive surgery and intraperitoneal chemotherapyDavid H Ilson
The Lancet. Gastroenterology & Hepatology|January 26, 2019
Stage II gastric cancer: 1 year of S-1 remains standard of careDavid H Ilson
Current Treatment Options in Oncology|August 15, 2006
Cancer of the gastroesophageal junction: Current therapy optionsDavid H Ilson
Gastrointestinal Cancer Research : GCR|March 5, 2009
Esophageal cancer chemotherapy: recent advancesDavid H Ilson
Pageof 17